Nationwide, we invest over $132 million a year ($3.2 billion since 1949) in heart and stroke research that has led to recent breakthroughs such as clot-busting drugs and drug-eluting stents. Healthcare providers learn about medical advances and new treatment guidelines though our journals, conferences and online courses.